Archives | window-to-japan.eu

RIKEN forms 34th venture company “TransSine Technologies”, technology base is promotion of protein synthesis by non-coding RNA

Oct 31, 2012

The scientific base of the company is centered in RIKEN’s omics center, Yokohama, around Piero Carninci’s team, in collaboration with the International School of Advanced Studies, Trieste. Nikkei Biotech, Oct. 31, 2012

Taisho Pharmaceutical’s sales of its health food for fat-control, Livita, reached 4 billion Yen in 6 months

Oct 31, 2012

Livita “Self-care” products, https://www.taisho.co.jp/livita/, directed against metabolic syndrome and related diseases, are under FOSHU labeling. Fat care” is a food for specified health use suitable for suppression of body fat absorption in the small intestine...

Takeda Pharmaceuticals applies in Japan for manufacturing and sales of Cetilistat, a gastric lipase inhibitor to be sold as an antiobesic drug

Oct 30, 2012

Takeda has applied jointly with Netherland’s Norgine Co. which owns all rights on this compound. Takeda Pharmaceuticals press release, Oct. 30, 2012

Kainos begins marketing of PCR-based kit for Clostridium perfringens, a food-borne pathogen

Oct 30, 2012

Detection limit is 10 e5 CFUs Kainos press release, Oct. 25, 2010

Consumer Agency adds 6 new FOSHU items, including “resistant starch”-containing products from Matsutani Chemical Industry

Oct 29, 2012

After the decision of the Consumer Agency on Oct. 24, total FOSHU agents are now 1019 (permitted) plus 1 (recognized). An interesting new area are products such as soba containing “resistant starch”, as offered by Matsutani Chemical Industry with claims of reducing...